NK-1 AND SEROTONIN TRANSPORTER INHIBITORS

摘要

The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating disorders associated with an excess or imbalance of tachykinins or serotonin or both. [ I ]